Loading...

Anavaj Sakuntabhai

Home / Investigators  / Anavaj Sakuntabhai

Anavaj Sakuntabhai

Head, Functional Genetics of Infectious Diseases, Pasteur Institute

Email: anavaj@pasteur.fr
Phone: 33 1 44 38 91 03

28 Rue du Docteur Roux, 75015 Paris, France

Website

Dr. Anavaj Sakuntabhai is a researcher specializing in human genetics of infectious diseases. He received his MD from Chulalongkorn University in Bangkok, Thailand and completed post-doctoral training in Internal Medicine and Dermatology at the Ramathibodi Hospital, Mahidol University. He also has a MD from the University of Newcastle in Tyne, UK.  Finally, he earned his PhD in Human Molecular Genetics from the University of Oxford. He joined the Institut Pasteur in Paris in 2000 as a Senior Scientist and in 2007 became the leader of the Laboratory of Genetics of Human Response to Infections. In 2010 he created and became the head of the Functional Genetics of Infectious Diseases Unit.

The Functional Genetics of Infectious Diseases unit studies the basis of human genetic susceptibility to major human pathogens. They currently focus on mosquito-borne infections (malaria and dengue). They aim to identify genes governing infection outcome and transmissibility, within two important contexts: 1) That of the pathogen exploitation of the host and maximization of onward transmission; 2) The environmental context, placing emphasis upon the exogenous factors that impact upon the within-host dynamic of the pathogen and thus influence the outcome of infection.

Recent Publications

  • Bonam, SR, Kaveri, SV, Sakuntabhai, A, Gilardin, L, Bayry, J. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients. Cell Rep Med. 2020;1 (2):100016. doi: 10.1016/j.xcrm.2020.100016. PubMed PMID:32562483 PubMed Central PMC7190525.
  • Faye, O, de Lourdes Monteiro, M, Vrancken, B, Prot, M, Lequime, S, Diarra, M et al.. Genomic Epidemiology of 2015-2016 Zika Virus Outbreak in Cape Verde. Emerging Infect. Dis. 2020;26 (6):1084-1090. doi: 10.3201/eid2606.190928. PubMed PMID:32441631 PubMed Central PMC7258482.
  • Teissier, Y, Paul, R, Aubry, M, Rodo, X, Dommar, C, Salje, H et al.. Long-term persistence of monotypic dengue transmission in small size isolated populations, French Polynesia, 1978-2014. PLoS Negl Trop Dis. 2020;14 (3):e0008110. doi: 10.1371/journal.pntd.0008110. PubMed PMID:32142511 PubMed Central PMC7080275.
  • Manet, C, Simon-Lorière, E, Jouvion, G, Hardy, D, Prot, M, Conquet, L et al.. Genetic Diversity of Collaborative Cross Mice Controls Viral Replication, Clinical Severity, and Brain Pathology Induced by Zika Virus Infection, Independently of Oas1b. J. Virol. 2020;94 (3):. doi: 10.1128/JVI.01034-19. PubMed PMID:31694939 PubMed Central PMC7000970.
  • Díez-Fuertes, F, De La Torre-Tarazona, HE, Calonge, E, Pernas, M, Alonso-Socas, MDM, Capa, L et al.. Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors. Sci Rep. 2019;9 (1):14265. doi: 10.1038/s41598-019-50642-x. PubMed PMID:31582776 PubMed Central PMC6776652.
  • Scepanovic, P, Hodel, F, Mondot, S, Partula, V, Byrd, A, Hammer, C et al.. A comprehensive assessment of demographic, environmental, and host genetic associations with gut microbiome diversity in healthy individuals. Microbiome. 2019;7 (1):130. doi: 10.1186/s40168-019-0747-x. PubMed PMID:31519223 PubMed Central PMC6744716.
  • Roth, C, Cantaert, T, Colas, C, Prot, M, Casadémont, I, Levillayer, L et al.. A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice. Front Immunol. 2019;10 :1424. doi: 10.3389/fimmu.2019.01424. PubMed PMID:31293584 PubMed Central PMC6598640.
  • Ly, S, Fortas, C, Duong, V, Benmarhnia, T, Sakuntabhai, A, Paul, R et al.. Asymptomatic Dengue Virus Infections, Cambodia, 2012-2013. Emerging Infect. Dis. 2019;25 (7):1354-1362. doi: 10.3201/eid2507.181794. PubMed PMID:31211672 PubMed Central PMC6590774.
  • Karnam, A, Stephen-Victor, E, Das, M, Magy, L, Vallat, JM, Bolgert, F et al.. Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection?. Autoimmun Rev. 2019;18 (6):632-633. doi: 10.1016/j.autrev.2019.01.004. PubMed PMID:30959213 .
  • Chaichoompu, K, Abegaz, F, Tongsima, S, Shaw, PJ, Sakuntabhai, A, Pereira, L et al.. IPCAPS: an R package for iterative pruning to capture population structure. Source Code Biol Med. 2019;14 :2. doi: 10.1186/s13029-019-0072-6. PubMed PMID:30936940 PubMed Central PMC6427891.
Search PubMed